| Symbol |
Name |
|
ABI1
|
abl-interactor 1
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ATR
|
ATR serine/threonine kinase
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CAT
|
catalase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCND1
|
cyclin D1
|
|
CD40LG
|
CD40 ligand
|
|
CD6
|
CD6 molecule
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ETV6
|
ets variant 6
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FLG
|
filaggrin
|
|
FOXM1
|
forkhead box M1
|
|
FZD3
|
frizzled class receptor 3
|
|
GCG
|
glucagon
|
|
GINS3
|
GINS complex subunit 3 (Psf3 homolog)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GPR87
|
G protein-coupled receptor 87
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTT
|
huntingtin
|
|
IFNG
|
interferon, gamma
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL2
|
interleukin 2
|
|
IL25
|
interleukin 25
|
|
IL4
|
interleukin 4
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
KIAA1524
|
KIAA1524
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MFSD12
|
major facilitator superfamily domain containing 12
|
|
MIR195
|
microRNA 195
|
|
MIR21
|
microRNA 21
|
|
MMP9
|
matrix metallopeptidase 9
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOTCH1
|
notch 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDZD2
|
PDZ domain containing 2
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCI
|
protein kinase C, iota
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPMT1
|
protein tyrosine phosphatase, mitochondrial 1
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RBL2
|
retinoblastoma-like 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SMAD5
|
SMAD family member 5
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TXNIP
|
thioredoxin interacting protein
|
|
WT1
|
Wilms tumor 1
|
|
YBX1
|
Y box binding protein 1
|
